Correlation Between PDS Biotechnology and Ultragenyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Ultragenyx, you can compare the effects of market volatilities on PDS Biotechnology and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Ultragenyx.

Diversification Opportunities for PDS Biotechnology and Ultragenyx

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between PDS and Ultragenyx is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Ultragenyx go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Ultragenyx

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Ultragenyx. In addition to that, PDS Biotechnology is 2.45 times more volatile than Ultragenyx. It trades about -0.24 of its total potential returns per unit of risk. Ultragenyx is currently generating about -0.32 per unit of volatility. If you would invest  5,469  in Ultragenyx on August 24, 2024 and sell it today you would lose (867.00) from holding Ultragenyx or give up 15.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Ultragenyx

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Ultragenyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

PDS Biotechnology and Ultragenyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and Ultragenyx

The main advantage of trading using opposite PDS Biotechnology and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.
The idea behind PDS Biotechnology Corp and Ultragenyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
CEOs Directory
Screen CEOs from public companies around the world